NL-OMON22507招募中不适用
Optimising treatment dosage for depression and comorbid personality disorders: a randomized clinical trial
PI/Arkin0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 18-65 years
- •- DSM-IV diagnosis of a major depressive episode or dysthymia
排除标准
- •- Non-Dutch speakers/readers
- •- Psychotic symptoms, bipolar disorder or current extreme substance dependence.
研究者
相似试验
已完成
不适用
Optimizing treatment dosage for depression and comorbid personality disorders: a randomized clinical trialDepression and personality disorders10027946NL-OMON50650Arkin, Amsterdam200
已完成
不适用
Microdose Antagonist Combination for Depression (MAC-D) Trial: combination of low dose naltrexone and flumazenil for treatment of major depressive disorderMental Health - DepressionMajor Depressive DisorderACTRN12621000310864Trexapharm Pty Ltd10
招募中
Unknown
Depression-intervention study for optimization of reconvalesence after strokeDRKS00033792niversitätsklinikum Augsburg75
招募中
2 期
Augmenting treatment for Major Depression with a Positivity-AAT-TrainingF32.0F32.1F32.2F33.0F33.1F33.2F34.1Mild depressive episodeModerate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode mildRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsDysthymiaDRKS00020463Clinical PsychologyBehavioural Science InstituteRadboud University Nijmegen200
已完成
不适用
Can EEG predict response to treatment in depression?CTRI/2019/07/020290GMCH Chandigarh80